FIELD: medicine; pharmaceuticals.
SUBSTANCE: group of inventions discloses a composition for preventing or treating influenza or pneumonia, which is caused by influenza, which contains a therapeutically effective amount of a peptide, which consists of 17 adjacent amino acids and contains hexamer TX1EX2X3E, where X1, X2 and X3 can represent any natural or non-natural amino acid, where peptide is cyclised and has no TNF receptor binding activity and inhibitor of virus neuraminidase, where cyclised peptide consists of a sequence of amino acids CGQRETPEGAEAKPWYC; a kit comprising said composition, as well as use thereof for preventing and/or treating influenza in pneumonia caused by influenza.
EFFECT: using inventions according to disclosed group allows to significantly increase therapeutic effect in treating infections caused by influenza viruses.
14 cl, 1 tbl, 3 dwg, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOSITIONS AND METHODS FOR TREATING VIRAL INFECTIONS | 2019 |
|
RU2816717C2 |
| IMMUNOGENIC COMPOSITIONS AND METHODS | 2008 |
|
RU2468034C2 |
| TREATING VASCULAR COMPLICATIONS OF DIABETES | 2010 |
|
RU2545718C2 |
| H7N9 INFLUENZA A THERAPY | 2015 |
|
RU2682049C2 |
| ANTIVIRAL SIMILAR MINI-ANTIBODY, NUCLEOTIDE SEQUENCE, EXPRESSING RECOMBINANT VIRAL VECTOR, PHARMACEUTICAL COMPOSITION AND METHOD FOR PREVENTION OR THERAPY OF INFLUENZA TYPE A | 2013 |
|
RU2536956C1 |
| NEUTRALISING ANTI-INFLUENZA A VIRUS ANTIBODIES AND USING THEM | 2009 |
|
RU2553325C2 |
| APPLICATION OF COMPOSITION CONSISTING OF CATIONIC LTP PEPTIDE AND MOLECULES OF RNA AGAINST RESPIRATORY VIRUSES | 2015 |
|
RU2609857C1 |
| PEPTIDES SUPPRESSING RESPIRATORY VIRUSE INFECTIONS, THEIR APPLICATION AND METHODS FOR OBTAINING | 2014 |
|
RU2639559C2 |
| COMPOSITIONS AND METHODS FOR TREATING INFLUENZA VIRUS | 2016 |
|
RU2736481C2 |
| INFLUENZA TREATMENT METHODS | 2018 |
|
RU2769317C2 |
